Amdocs Limited DOX
- Market cap
- $6.2B
- P/E
- 13.7×
Follow DOX
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.06 | 56.10 | 55.89 | 52.60 | 44.05 | 67.40 | 72.63 | 78.38 | 74.41 | 74.32 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 61.33 | 67.98 | 71.72 | 72.89 | 77.29 | 82.38 | 91.24 | 99.75 | 94.04 | 95.41 |
High Price
|
|||
| 25,561 | 24,670 | 24,381 | 24,516 | 25,875 | 27,176 | 30,288 | 30,695 | 29,058 | 26,969 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 3,718 | 3,867 | 3,975 | 4,087 | 4,169 | 4,289 | 4,577 | 4,888 | 5,005 | 4,533 |
Revenue
|
|||
| 35.24% | 35.16% | 34.71% | 35.08% | 33.90% | 34.46% | 35.38% | 35.35% | 35.07% | 37.98% |
Gross Margin
|
|||
| 485 | 513 | 422 | 568 | 583 | 814 | 648 | 636 | 591 | 693 |
EBT
|
|||
| 13.04% | 13.26% | 10.61% | 13.90% | 13.99% | 18.99% | 14.17% | 13.02% | 11.81% | 15.29% |
EBT Margin
|
|||
| 409 | 437 | 354 | 479 | 498 | 688 | 550 | 543 | 496 | 568 |
Net Income
|
|||
| 212 | 215 | 211 | 206 | 199 | 209 | 225 | 196 | 196 | 196 |
Depreciation
|
|||
| 25.15 | 26.70 | 28.12 | 29.94 | 31.44 | 33.72 | 37.81 | 41.54 | 44.17 | 41.56 |
Revenue/Sh
|
|||
| 2.74 | 2.99 | 2.49 | 3.49 | 3.73 | 5.36 | 4.47 | 4.52 | 4.27 | 5.08 |
Earnings/Sh
|
|||
| 4.19 | 4.39 | 3.94 | 4.81 | 4.96 | 7.28 | 6.25 | 6.99 | 6.39 | 6.87 |
Cash Flow/Sh
|
|||
| 1.57 | (0.92) | (1.64) | (0.94) | (1.55) | (1.65) | (1.88) | (0.84) | (0.93) | (0.95) |
Capex/Sh
|
|||
| 5.76 | 3.47 | 2.31 | 3.87 | 3.41 | 5.62 | 4.37 | 6.16 | 5.46 | 5.92 |
Free CF/Sh
|
|||
| 23.36 | 24.68 | 24.70 | 25.96 | 27.64 | 28.58 | 29.41 | 30.32 | 30.88 | 31.82 |
Book Value/Sh
|
|||
| 148 | 145 | 141 | 136 | 133 | 127 | 121 | 118 | 113 | 109 |
Shares
|
|||
| 21.04 | 21.55 | 26.57 | 18.94 | 15.39 | 14.18 | 17.77 | 18.67 | 20.49 | 16.18 |
PE Ratio
|
|||
| 2.30 | 2.42 | 2.33 | 2.21 | 1.83 | 2.25 | 2.10 | 2.02 | 1.98 | 1.97 |
PS Ratio
|
|||
| 2.48 | 2.62 | 2.66 | 2.55 | 2.08 | 2.65 | 2.70 | 2.77 | 2.83 | 2.58 |
PB Ratio
|
|||
| 2.06 | 2.22 | 2.23 | 2.12 | 1.82 | 2.23 | 2.10 | 2.04 | 2.04 | 2.09 |
EV/Sales
|
|||
| 8.99 | 17.07 | 27.22 | 16.41 | 16.80 | 13.34 | 18.18 | 13.74 | 16.46 | 14.65 |
EV/FCF
|
|||
| 620 | 636 | 557 | 656 | 658 | 926 | 757 | 823 | 724 | 749 |
Op' Cash Flow
|
|||
| 232 | (133) | (231) | (128) | (206) | (210) | (227) | (98) | (105) | (104) |
Capex
|
|||
| 852 | 503 | 326 | 528 | 453 | 715 | 530 | 724 | 619 | 645 |
FCF
|
|||
| 734 | 876 | 426 | 468 | 858 | 764 | 750 | 558 | 300 | 233 |
Working Cap'
|
|||
| 200 | — | — | — | 974 | 881 | 826 | 807 | 750 | 788 |
Total Debt
|
|||
| (896) | (980) | (519) | (472) | (10) | (84) | 9 | 65 | 235 | 463 |
Net Debt
|
|||
| 3,454 | 3,574 | 3,492 | 3,542 | 3,665 | 3,635 | 3,560 | 3,567 | 3,499 | 3,471 |
Sh' Equity
|
|||
| 7.68% | 8.17% | 6.62% | 8.95% | 8.50% | 10.60% | 8.40% | 8.29% | 7.55% | 8.77% |
ROA
|
|||
| 11.81% | 12.46% | 9.00% | 11.60% | 10.17% | 10.54% | 11.64% | 11.25% | 10.52% | 11.63% |
ROIC
|
|||
| 11.93% | 12.33% | 9.96% | 13.54% | 13.71% | 18.67% | 15.05% | 14.92% | 13.70% | 15.90% |
ROE
|
|||
Amdocs Limited peers in Software Infrastructure
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| WEX WEX Inc. | $6.3B | 17.5× | Compare |
| QLYS Qualys, Inc. | $6.3B | 29.7× | Compare |
| BLSH Bullish | $6.0B | 0.0× | Compare |
| CORZ Core Scientific, Inc. | $5.9B | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| PATH UiPath, Inc. | $6.6B | 18.6× | Compare |
| VRNS Varonis Systems, Inc. | $5.5B | 0.0× | Compare |
| DBX Dropbox, Inc. | $7.1B | 17.7× | Compare |
| ZETA Zeta Global Holdings Corp. | $7.4B | 0.0× | Compare |
Amdocs Limited (DOX) key facts
- Amdocs Limited (DOX) is a Software Infrastructure company in the Technology sector, listed on Nasdaq.
- Amdocs Limited’s revenue for fiscal 2025 (year ended September 2025) was $4.5 billion, down 9.43% from fiscal 2024.
- As of September 25, 2026, DOX traded at $57.71, a market capitalization of $6.2 billion.
- Amdocs Limited pays an annual dividend of $1.74 per share, a yield of 1.98%, with a payout ratio of 35.6%.
- Return on equity was 15.9% and debt-to-equity 0.32.
Amdocs Limited (DOX) Latest News
24 Sep
Amdocs (DOX) is labeled a sell amid revenue declines, tepid expected growth, and shrinking returns on capital in a competitive environment. The piece notes customers delaying purchases, projects around 3.4% growth, and a 7.5x forward P/E at $58.36. It contrasts DOX with Dell (buy) and Kforce (sell), while acknowledging industry gains of 22.8% over six months but warning that demand in business services remains tied to the broader economy. Declining revenue, tepid forward growth, and shrinking returns amid competition could curb DOX's earnings trajectory.
22 Sep
Amdocs (DOX) trades at $59.50 and has fallen 8.6% over six months, lagging the S&P 500's 16.2% gain. Three risk factors are cited: long-term revenue growth has been weak (5-year CAGR of 1.8%), 12-month revenue growth is forecast at just 3.4% (below sector averages), and ROIC has declined by about 3 percentage points per year, signaling fading profitable growth opportunities. The stock's forward P/E is about 7.5x, suggesting cheap valuation but meaningful downside given fundamentals. A more attractive pick is described as the most dominant software business in the world, with additional promotion of momentum stocks via an AI platform. Three explicit red flags (sluggish long-term growth, slim near-term growth, and declining ROIC) imply meaningful downside despite valuation, though the piece favors an alternative stock and momentum plays.
4 Sep
Amdocs (DOX) stock rose 7% since last earnings report on positive investor reaction to financial results and outlook. Post-earnings share gains reflect moderate lift to near-term sentiment and valuation without major operational changes.
29 Aug
Amdocs secured an AI-driven deal with Telefonica Chile that targets managed services expansion and could reshape the company's operational trajectory. AI-driven Telefonica Chile contract marks a major strategic move capable of significantly shifting Amdocs managed services path and investor view.
13 Aug
Amdocs Limited pursues growth in telco AI by developing agentic platforms and advancing edge computing capabilities. Strategic push into AI platforms and edge computing targets major telco opportunities and could significantly alter Amdocs trajectory.
Amdocs Limited (DOX) released its Q3 2026 earnings call transcript covering financial results, operational updates, and forward outlook. Quarterly earnings transcripts deliver financial metrics that moderately shape near-term investor views and stock movement.
11 Aug
Amdocs Limited's Q2 results highlight Agentic Strategy and aOS Platform as primary drivers of customer engagement. Agentic Strategy and aOS Platform advances point to noticeable but not transformative effects on Amdocs competitive positioning and performance.
6 Aug
Amdocs Limited reported third-quarter earnings that met estimates, with managed services reaching record levels. Record managed services and in-line earnings indicate moderate positive effects on near-term revenue stability.
Amdocs Limited held its Q3 2026 earnings call covering quarterly financial results, operational updates and forward guidance. Quarterly earnings release and guidance directly inform near-term revenue, margins and investor expectations.
5 Aug
Amdocs Limited reported third quarter fiscal 2026 results including revenue, earnings per share, and forward guidance. Quarterly earnings data directly shapes investor views on valuation and near-term trajectory.
Liberty Latin America announces 10-year strategic engagement with Amdocs Limited. 10-year engagement secures major long-term revenue and bolsters Amdocs position in Latin America.
Amdocs Limited held its Q3 earnings call, presenting highlights on financial results, operations, and outlook. Routine quarterly earnings updates typically yield moderate short-term market effects without major strategic shifts.
Amdocs Limited (DOX) Q3 earnings key metrics are analyzed for insights into financial and operational performance. Q3 earnings metrics analysis can moderately shape Amdocs investor sentiment and near-term stock trajectory.
Cielo selects Amdocs to implement intelligent connectivity across its entire Brazilian payment terminal network. Contract expands Amdocs presence in Brazilian payments infrastructure.
Optimum implements Amdocs aOS Cognitive Core to power an AI-enhanced platform that transforms its customer billing experience. Optimum deployment validates Amdocs AI billing technology and supports modest revenue growth without shifting overall trajectory.
Lumen extends multi-cloud strategy via partnership with Amdocs to modernize enterprise service orchestration. Deal with Lumen supports Amdocs enterprise growth but remains one contract among broader operations.
PLDT Home selects Amdocs to modernize its core business platform, advancing cloud-ready transformation. PLDT Home contract win supports Amdocs revenue growth in telecom modernization.
Sunrise extends strategic collaboration with Amdocs to advance CRM evolution using aOS. Extended Sunrise partnership supports Amdocs revenue and aOS adoption in telecom without broad market shift.
Vivo selects Amdocs to advance OSS modernization with upgrade to Amdocs CES2X. Vivo contract for OSS upgrade adds moderate revenue and positions Amdocs in telecom modernization.
Amdocs (DOX) could be 31% undervalued following Q2 earnings focus. Q2 earnings valuation analysis indicates moderate potential to influence investor sentiment and stock trajectory.
13 Jul
Amdocs Limited secures a deal with Three Scandinavia alongside new analyst coverage that may shift investment outlook for the company. Scandinavia contract and fresh coverage point to moderate effects on Amdocs operations and investor views.
Amdocs (DOX) stock may trade below fair value following AI RAN news. AI RAN news creates competitive pressure that can shift Amdocs valuation and short-term market sentiment.
8 Jul
Amdocs (DOX) encounters significant difficulties advancing its AI initiatives, threatening operational efficiency and long-term market positioning. AI implementation struggles may slow product innovation and affect competitive standing without fundamentally reshaping company trajectory.
2 Jul
Amdocs (DOX) with 1Finity and Supermicro (SMCI) validated an AI-RAN blueprint on NVIDIA (NVDA) infrastructure. AI-RAN blueprint validation expands Amdocs telecom software positioning in emerging AI infrastructure.
24 Jun
Amdocs selected by Three Scandinavia to support customer engagement transformation across Nordic markets. Contract win adds revenue and Nordic footprint for Amdocs but remains incremental to overall operations.
23 Jun
Amdocs launches live multivendor AI-RAN solution and industry blueprint to advance aOS network workflows. Multivendor AI-RAN launch strengthens Amdocs position in telecom network automation and 5G infrastructure.
21 May
Microsoft and Amdocs deepen collaboration on Azure cloud services while Workday adopts Microsoft 365 Copilot. Expanded Azure partnership strengthens Amdocs cloud positioning and opens incremental revenue opportunities without altering core trajectory.
Amdocs Limited partners with Alphabet Inc. to expand the Gemini Enterprise Agent Marketplace, integrating Amdocs solutions into Google's AI enterprise offerings. Partnership integrates Amdocs into Alphabet's Gemini AI marketplace, offering moderate gains in product reach and positioning within enterprise software.
15 May
Amdocs reported mixed Q2 2026 results, with revenue slightly missing estimates but EPS beating, alongside positive traction updates for its aOS platform, suggesting cautious optimism for shareholders amid strategic AI advancements. Mixed quarterly earnings and product traction updates will moderately affect financial performance and competitive positioning without fundamentally altering long-term trajectory.
14 May
Amdocs Q2 earnings surpassed analyst estimates, with revenues rising year-over-year. Q2 earnings beat and year-over-year revenue growth demonstrate strong financial performance, likely boosting stock price and investor sentiment.